Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Plasma Phospho‐Tau Identifies Alzheimer's Co‐Pathology in Patients with Lewy Body Disease
Sara Hall, Shorena Janelidze, Elisabet Londos, et al.
Movement Disorders (2020) Vol. 36, Iss. 3, pp. 767-771
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231
Sherif Bayoumy, Inge M.W. Verberk, Ben den Dulk, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 139
Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy
Leonidas Chouliaras, Alan Thomas, Maura Malpetti, et al.
Journal of Neurology Neurosurgery & Psychiatry (2022) Vol. 93, Iss. 6, pp. 651-658
Open Access | Times Cited: 123
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Fernándo González‐Ortiz, Przemysław R. Kac, Wagner S. Brum, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 105
Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias
Simone Baiardi, Corinne Quadalti, Angela Mammana, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 99
Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy Bodies
Maria Camila González, Nicholas J. Ashton, Bárbara Fernandes Gomes, et al.
JAMA Neurology (2021) Vol. 79, Iss. 1, pp. 32-32
Open Access | Times Cited: 63
The central role of tau in Alzheimer’s disease: From neurofibrillary tangle maturation to the induction of cell death
Dietmar Rudolf Thal, Sandra O. Tomé
Brain Research Bulletin (2022) Vol. 190, pp. 204-217
Open Access | Times Cited: 46
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers
Lucy L. Gibson, Carla Abdelnour, Joyce R. Chong, et al.
Current Opinion in Neurology (2023)
Open Access | Times Cited: 23
Plasma biomarkers of Alzheimer's disease in the continuum of dementia with Lewy bodies
Patricia Diaz‐Galvan, Scott A. Przybelski, Alicia Algeciras‐Schimnich, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 4, pp. 2485-2496
Open Access | Times Cited: 9
Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration
Ying Jiang, John Alam, Stephen N. Gomperts, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 35
Fluid and Biopsy Based Biomarkers in Parkinson's Disease
David G. Coughlin, David J. Irwin
Neurotherapeutics (2023) Vol. 20, Iss. 4, pp. 932-954
Open Access | Times Cited: 21
Neuroinflammation is linked to dementia risk in Parkinson’s disease
Antonina Kouli, Lennart R. B. Spindler, Tim D. Fryer, et al.
Brain (2023) Vol. 147, Iss. 3, pp. 923-935
Open Access | Times Cited: 18
Association of Plasma Phosphorylated Tau With the Response to Neflamapimod Treatment in Patients With Dementia With Lewy Bodies
John Alam, Paul Maruff, Susan R. Doctrow, et al.
Neurology (2023) Vol. 101, Iss. 17
Open Access | Times Cited: 16
Clinical and diagnostic implications of Alzheimer’s disease copathology in Lewy body disease
Lorenzo Barba, Samir Abu‐Rumeileh, Henryk Barthel, et al.
Brain (2024) Vol. 147, Iss. 10, pp. 3325-3343
Closed Access | Times Cited: 7
All the Tau We Cannot See
Bradley T. Hyman
Annual Review of Medicine (2022) Vol. 74, Iss. 1, pp. 503-514
Open Access | Times Cited: 23
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease
Andrea Pilotto, Nicholas J. Ashton, Alessandro Lupini, et al.
Journal of Neurology (2024)
Open Access | Times Cited: 5
Plasma biomarkers of amyloid, tau, axonal, and neuroinflammation pathologies in dementia with Lewy bodies
Agathe Vrillon, Olivier Bousiges, Karl Götze, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Advances in Blood Biomarkers for Alzheimer’s Disease: Ultra-Sensitive Detection Technologies and Impact on Clinical Diagnosis
Yi Zhang, Kefan Bi, Linfu Zhou, et al.
Degenerative Neurological and Neuromuscular Disease (2024) Vol. Volume 14, pp. 85-102
Open Access | Times Cited: 4
Plasma biomarkers of amyloid, tau, astrogliosis, and axonal injury in a mixed memory clinic cohort
Helena Sophia Gleerup, Anja Hviid Simonsen, Lana Grötschel, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2025) Vol. 17, Iss. 1
Open Access
Polygenic risk discriminates Lewy body dementia from Alzheimer's disease
Anna McKeever, Peter Swann, Maura Malpetti, et al.
Alzheimer s & Dementia (2025)
Open Access
Sex Differences for Clinical Correlates of Alzheimer's Pathology in People with Lewy Body Pathology
Ece Bayram, David G. Coughlin, Irene Litvan
Movement Disorders (2022) Vol. 37, Iss. 7, pp. 1505-1515
Open Access | Times Cited: 21
A Longitudinal Study of Plasma pTau181 in Mild Cognitive Impairment with Lewy Bodies and Alzheimer's Disease
Alan Thomas, Calum A. Hamilton, Amanda Heslegrave, et al.
Movement Disorders (2022) Vol. 37, Iss. 7, pp. 1495-1504
Open Access | Times Cited: 19
Dissociable contribution of plasma NfL and p-tau181 to cognitive impairment in Parkinson's disease
Javier Pagonabarraga, Rocío Pérez‐González, Helena Bejr‐Kasem, et al.
Parkinsonism & Related Disorders (2022) Vol. 105, pp. 132-138
Closed Access | Times Cited: 18
Tau proteins in blood as biomarkers of Alzheimer’s disease and other proteinopathies
Federico Verde
Journal of Neural Transmission (2022) Vol. 129, Iss. 2, pp. 239-259
Closed Access | Times Cited: 17
Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium
Gregory D. Scott, Moriah R. Arnold, Thomas G. Beach, et al.
Frontiers in Neurology (2022) Vol. 12
Open Access | Times Cited: 17
The relationship between plasma biomarkers and amyloid PET in dementia with Lewy bodies
Paul C. Donaghy, Michael Firbank, George Petrides, et al.
Parkinsonism & Related Disorders (2022) Vol. 101, pp. 111-116
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top